This concept was taken further by utilizing an scFv targeting B7H6, a ligand for NKp30, to create a CAR that targets multiple tumor cells while demonstrating an impressive safety profile, since B7H6 is not constitutively expressed on healthy tissues (191). The gene discussed is NCR3LG1; the disease is neoplasm.